Physician
Hackensack Meridian Health Medical Group - Specialty Care PC
Hackensack Meridian Health Medical Group - Specialty Care PC was paid $50.09M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoHACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC
RED BANK, NJ 07701
RED BANK, NJ 07701
33aNPI1215989249assigned 05/17/2006
33bProvider typeOral & Maxillofacial Surgery (D.M.D.)
28Total paid$50.09M
24GClaims913,147
24DCodes billed244
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Oral & Maxillofacial Surgery (D.M.D.) providers in New Jersey
Rank by total paid#1 of 10
Median peer was paid$33K
This provider vs. median1,523×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,699 | $4.09M | |
| 2019 | 58,643 | $3.84M | |
| 2020 | 52,447 | $3.14M | |
| 2021 | 80,713 | $5.48M | |
| 2022 | 133,979 | $7.41M | |
| 2023 | 288,157 | $13.91M | |
| 2024incomplete | 242,509 | $12.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 121,036 | 106,614 | $8.78M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 110,891 | 102,889 | $8.48M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.4% | 87,050 | 74,989 | $4.72M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 43,721 | 38,753 | $3.73M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.5% | 81,259 | 29,417 | $2.26M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.9% | 39,722 | 38,065 | $1.98M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.9% | 16,220 | 15,500 | $1.96M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2.9% | 6,398 | 5,171 | $1.45M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 11,720 | 10,504 | $1.32M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.4% | 12,214 | 4,623 | $1.19M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.3% | 14,378 | 13,502 | $1.17M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 9,975 | 9,719 | $931K |
232 more codes
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.8% | 24,128 | $885K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 9,945 | $598K |
| 99205 | Prolong outpt/office vis | 1.1% | 4,336 | $556K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 20,123 | $554K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.1% | 18,030 | $553K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 8,342 | $456K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14,328 | $439K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 81,122 | $352K |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | <1% | 1,392 | $341K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 2,702 | $333K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 1,933 | $296K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,277 | $276K |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 1,119 | $263K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 2,192 | $252K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,079 | $242K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,978 | $239K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 3,321 | $237K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 4,713 | $221K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,412 | $221K |
| 93000 | <1% | 15,342 | $209K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,422 | $206K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 10,332 | $195K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,613 | $168K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,064 | $167K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,546 | $161K |
| 95782 | <1% | 1,243 | $159K | |
| 59426 | <1% | 1,170 | $155K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 3,099 | $148K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,613 | $142K |
| 93325 | <1% | 6,188 | $134K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 1,576 | $127K |
| 76830 | Ultrasound, transvaginal | <1% | 1,015 | $114K |
| 99460 | <1% | 2,274 | $107K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 502 | $99K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 162 | $86K |
| 93320 | <1% | 1,908 | $86K | |
| 99442 | <1% | 3,037 | $84K | |
| 93970 | <1% | 3,162 | $82K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 3,319 | $80K |
| 95720 | <1% | 980 | $77K | |
| 59425 | <1% | 712 | $73K | |
| 99243 | <1% | 609 | $73K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 411 | $64K |
| 99443 | <1% | 1,458 | $64K | |
| 99292 | <1% | 1,619 | $60K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 761 | $54K |
| 76813 | <1% | 1,153 | $50K | |
| 29581 | <1% | 1,888 | $50K | |
| 94729 | <1% | 1,901 | $49K | |
| 94060 | <1% | 2,448 | $49K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,679 | $48K |
| 99383 | <1% | 109 | $48K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,316 | $48K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,846 | $48K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 666 | $41K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,207 | $41K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 145 | $41K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,192 | $40K |
| 94727 | <1% | 1,950 | $39K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 284 | $38K |
| 99242 | <1% | 406 | $37K | |
| 99245 | <1% | 159 | $35K | |
| 29580 | <1% | 1,785 | $34K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 480 | $34K |
| 94010 | <1% | 3,731 | $32K | |
| 99384 | <1% | 91 | $32K | |
| 99254 | <1% | 220 | $27K | |
| 95024 | <1% | 319 | $26K | |
| 97803 | <1% | 1,173 | $24K | |
| 69210 | <1% | 537 | $23K | |
| D9420 | <1% | 104 | $22K | |
| 99385 | <1% | 211 | $21K | |
| 99221 | <1% | 545 | $20K | |
| 95800 | <1% | 401 | $20K | |
| 93016 | <1% | 2,011 | $19K | |
| 99235 | <1% | 130 | $18K | |
| 20610 | <1% | 537 | $18K | |
| 97802 | <1% | 539 | $18K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 306 | $18K |
| 81025 | <1% | 3,154 | $17K | |
| 99386 | <1% | 131 | $16K | |
| 93880 | <1% | 852 | $16K | |
| 90870 | <1% | 678 | $15K | |
| 31575 | <1% | 133 | $15K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 735 | $14K |
| 99462 | <1% | 661 | $14K | |
| 90461 | <1% | 502 | $14K | |
| 95886 | <1% | 356 | $14K | |
| 93018 | <1% | 2,010 | $13K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 327 | $13K |
| 92511 | <1% | 79 | $12K | |
| 95251 | <1% | 640 | $12K | |
| 99219 | <1% | 131 | $12K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 52 | $11K |
| 76820 | <1% | 570 | $11K | |
| 64644 | <1% | 267 | $11K | |
| 95806 | <1% | 241 | $11K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 716 | $11K |
| 99253 | <1% | 190 | $10K | |
| 95811 | <1% | 108 | $10K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,867 | $10K |
| 93224 | <1% | 221 | $8K | |
| 76821 | <1% | 320 | $8K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 173 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 626 | $8K |
| 93971 | <1% | 476 | $7K | |
| 73130 | <1% | 371 | $7K | |
| 99252 | <1% | 125 | $7K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 105 | $7K |
| 93321 | <1% | 573 | $7K | |
| 95816 | <1% | 200 | $6K | |
| 95250 | <1% | 152 | $6K | |
| 64643 | <1% | 160 | $6K | |
| 95819 | <1% | 163 | $5K | |
| 93304 | <1% | 162 | $5K | |
| 99497 | <1% | 265 | $5K | |
| 59430 | <1% | 25 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 229 | $5K |
| 52000 | <1% | 24 | $5K | |
| 95722 | <1% | 27 | $5K | |
| 59025 | Fetal non-stress test | <1% | 154 | $5K |
| 90682 | <1% | 103 | $4K | |
| 0011A | <1% | 128 | $4K | |
| 0012A | <1% | 119 | $4K | |
| 93308 | <1% | 91 | $4K | |
| 93356 | <1% | 251 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 188 | $4K |
| 99441 | <1% | 435 | $4K | |
| 95718 | <1% | 69 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 88 | $3K |
| 76801 | <1% | 92 | $3K | |
| 76825 | <1% | 13 | $3K | |
| 99255 | <1% | 27 | $3K | |
| 51798 | <1% | 203 | $3K | |
| 99336 | <1% | 183 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,034 | $3K |
| 20611 | <1% | 70 | $3K | |
| 90836 | <1% | 43 | $3K | |
| 99464 | <1% | 36 | $2K | |
| 73564 | <1% | 101 | $2K | |
| 64483 | <1% | 16 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 163 | $2K |
| 95874 | <1% | 389 | $2K | |
| 93458 | <1% | 16 | $2K | |
| 97597 | <1% | 63 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 214 | $2K |
| D9310 | <1% | 97 | $2K | |
| 93922 | <1% | 117 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 14 | $2K |
| 95909 | <1% | 55 | $2K | |
| 88150 | <1% | 245 | $2K | |
| 73030 | <1% | 70 | $2K | |
| 92567 | <1% | 113 | $1K | |
| 72110 | <1% | 52 | $1K | |
| 88312 | <1% | 77 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 897 | $1K |
| 90686 | <1% | 515 | $1K | |
| D0367 | <1% | 69 | $1K | |
| 11721 | <1% | 109 | $1K | |
| 85027 | <1% | 512 | $1K | |
| 92550 | <1% | 90 | $1K | |
| 88142 | <1% | 80 | $1K | |
| 92588 | <1% | 45 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 245 | $1K |
| 93244 | <1% | 96 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 124 | $1K |
| 76827 | <1% | 13 | $971.65 | |
| 64615 | <1% | 22 | $963.53 | |
| 70355 | <1% | 80 | $929.11 | |
| 92557 | <1% | 31 | $923.82 | |
| 81002 | <1% | 1,174 | $901.20 | |
| 76706 | <1% | 172 | $872.17 | |
| 82962 | <1% | 1,797 | $843.82 | |
| 93015 | <1% | 12 | $731.99 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 47 | $684.51 |
| 99349 | <1% | 14 | $667.85 | |
| 51741 | <1% | 61 | $658.39 | |
| 77065 | Tomosynthesis, mammo | <1% | 33 | $653.66 |
| 88313 | <1% | 91 | $651.46 | |
| 88342 | <1% | 63 | $621.24 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 53 | $569.52 |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 46 | $549.61 |
| 99152 | <1% | 51 | $529.37 | |
| 99348 | <1% | 33 | $498.69 | |
| 82948 | <1% | 162 | $495.42 | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | <1% | 49 | $478.18 |
| 96132 | <1% | 73 | $449.72 | |
| 99217 | <1% | 13 | $447.58 | |
| 93925 | <1% | 28 | $432.70 | |
| 94664 | <1% | 187 | $383.12 | |
| 90674 | <1% | 15 | $359.38 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 104 | $283.00 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 29 | $269.16 |
| 99459 | <1% | 17 | $248.65 | |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | <1% | 52 | $220.53 |
| 94200 | <1% | 21 | $189.98 | |
| 77062 | <1% | 25 | $165.60 | |
| 36410 | <1% | 15 | $161.40 | |
| 70350 | <1% | 12 | $160.04 | |
| 76937 | <1% | 35 | $140.35 | |
| 90863 | <1% | 122 | $121.33 | |
| 93298 | <1% | 14 | $110.80 | |
| 93923 | <1% | 14 | $110.67 | |
| 82272 | <1% | 27 | $91.26 | |
| 90662 | <1% | 12 | $83.01 | |
| 73110 | <1% | 17 | $74.06 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 19 | $60.84 |
| 62370 | <1% | 14 | $51.05 | |
| 81001 | <1% | 13 | $40.03 | |
| 99417 | Prolong home eval add 15m | <1% | 150 | $32.97 |
| 99367 | <1% | 21 | $24.51 | |
| 96160 | <1% | 12 | $19.25 | |
| 36416 | <1% | 322 | $18.19 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 21 | $17.08 |
| 90633 | <1% | 25 | $2.00 | |
| 90670 | <1% | 129 | $1.00 | |
| G9781 | Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons) | 0% | 95 | $0.00 |
| 0502F | 0% | 1,324 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 158 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,295 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 201 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 12 | $0.00 |
| G2122 | Depression, anxiety, apathy, and psychosis not assessed | 0% | 16 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 857 | $0.00 |
| 90680 | 0% | 45 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 159 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 667 | $0.00 |
| 1126F | 0% | 113 | $0.00 | |
| 90698 | 0% | 48 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 199 | $0.00 |
| 90744 | 0% | 14 | $0.00 | |
| 91301 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVARGA, DANIEL (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Hackensack Meridian Health Medical Group - Primary Care PC | Red Bank, NJ | $21.84M |
| Hackensack Meridian Health Medical Group - Complex Care PC | Red Bank, NJ | $11.60M |
| Hackensack Meridian Health Medical Group - Specialty Care PC | Red Bank, NJ | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.